Cargando…
Differentiating Medicated Patients Suffering from Major Depressive Disorder from Healthy Controls by Spot Urine Measurement of Monoamines and Steroid Hormones
Introduction: Major Depressive Disorder (MDD) is a common psychiatric disorder. Currently, there is no objective, cost-effective and non-invasive method to measure biological markers related to the pathogenesis of MDD. Previous studies primarily focused on urinary metabolite markers which are not pr...
Autores principales: | Wijaya, Chandra S., Lee, Jovia J. Z., Husain, Syeda F., Ho, Cyrus S. H., McIntyre, Roger S., Tam, Wilson W., Ho, Roger C. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5981904/ https://www.ncbi.nlm.nih.gov/pubmed/29701669 http://dx.doi.org/10.3390/ijerph15050865 |
Ejemplares similares
-
Premenopausal Singaporean Women Suffering from Major Depressive Disorder Treated with Selective Serotonin Reuptake Inhibitors Had Similar Bone Mineral Density as Compared with Healthy Controls
por: Ho, Roger C., et al.
Publicado: (2022) -
IL-1β, IL-6, TNF- α and CRP in Elderly Patients with Depression or Alzheimer’s disease: Systematic Review and Meta-Analysis
por: Ng, Ada, et al.
Publicado: (2018) -
Identifying neuroimaging biomarkers of major depressive disorder from cortical hemodynamic responses using machine learning approaches
por: Li, Zhifei, et al.
Publicado: (2022) -
Factors Associated with the Risk of Developing Coronary Artery Disease in Medicated Patients with Major Depressive Disorder
por: Ho, Roger C. M., et al.
Publicado: (2018) -
Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review
por: Rosenblat, Christian, et al.
Publicado: (2015)